{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-095372","form_type":"8-K","ticker":"WAY","cik":"0001990354","company_name":"Waystar Holding Corp.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.226269+00:00","generated_at":"2026-05-17T05:09:13.686607+00:00","sec_items":["1.01","2.03","3.02","5.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Waystar closes Iodine acquisition for ~$459M cash + 16.6M shares; debt amended","bullets":["Acquisition completed Oct 1, 2025; total consideration ~$458.6M cash plus 16.64M shares valued at $37.31/share.","Combined company unites financial and clinical AI; expands TAM by >15% with Iodine's 1,000+ hospital clients.","Waystar expects immediate accretion to gross margin and adjusted EBITDA margin; revenue and non-GAAP EPS accretive in 2027.","Credit facility amended: $250M incremental term loans, revolver increased to $500M, interest rates reduced.","Board expanded to 13; Lauren Young (Advent MD) appointed as Class II director."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-095372","json":"https://secwatch.observer/filing/0001104659-25-095372.json","markdown":"https://secwatch.observer/filing/0001104659-25-095372.md","text":"https://secwatch.observer/filing/0001104659-25-095372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1990354/000110465925095372/0001104659-25-095372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1990354/000110465925095372/tm2527690d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:09:13.686607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"44f393f2155be1a48a39e0f947523a3caba7941f","claim":"Waystar Holding Corp. amended revolving credit of from $400.0 million to $500.0 million with JPMorgan Chase Bank, N.A. at Adjusted Term SOFR (as defined in the Credit Agreement), plus an initial applica.","evidence_excerpt":"the maximum borrowing capacity under the revolving credit facility under the Credit Agreement (the \"Revolving Credit Facility\"), was increased from $400.0 million to $500.0 million","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1990354/000110465925095372/0001104659-25-095372-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"from $400.0 million to $500.0 million"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A."},{"label":"Rate","value":"Adjusted Term SOFR (as defined in the Credit Agreement), plus an initial applica"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"d4d444b4d8f0fe79634667292469c9e966ba6be2","claim":"Waystar Holding Corp. incurred term loan of $250.0 million with JPMorgan Chase Bank, N.A..","evidence_excerpt":"the Borrower incurred incremental term loans in an aggregate principal amount of $250.0 million (the \"Incremental Term Loans\")","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1990354/000110465925095372/0001104659-25-095372-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$250.0 million"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A."},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}